Breast Fillers Market - Forecast, COVID-19 Impact, Trend Analysis & Competition Tracking - Global Insights 2018-2033

The Growing Incidence of Breast Cancer Offers a Favorable Market Opportunity with Substantial Potential for Growth

The global market for breast cancer treatment and procedures is expected to witness significant growth throughout the forecast period, primarily driven by the rising prevalence of breast cancer among women. Breast cancer is the most common type of cancer affecting women worldwide, and its incidence is increasing due to factors such as the aging population and lifestyle changes. According to data from the World Health Organisation (WHO), there are over 2.3 million cases of breast cancer diagnosed each year, highlighting the scale of the disease. In addition to the medical aspect, there is also a growing interest among women in breast enlargement and reconstructive procedures for aesthetic purposes. The increasing incidence of breast cancer, coupled with higher survival rates and improved insurance coverage, has contributed to a greater demand for breast fillers and reconstructive surgeries. In 2021 alone, 365,000 breast augmentations were performed, indicating the growing preference for these procedures. Breast reconstruction plays a crucial role in helping individuals regain their confidence and comfort after undergoing mastectomy or lumpectomy due to breast cancer or other medical conditions. This aspect further fuels the demand for breast fillers and reconstructive surgeries. Considering these factors, the market for breast cancer treatments and procedures is expected to experience sustained growth in the coming years, driven by the rising prevalence of breast cancer, increased survival rates, and the growing awareness and availability of reconstructive options.

Breast Fillers Are Gaining Traction as Women Seek Non-Surgical Breast Augmentation Solutions

The market for breast fillers has expanded in recent years as more women consider non-surgical breast enhancement options. This is due to a number of factors, including a desire for a more natural-looking result, a lesser risk of complications when compared to surgical breast enhancement, and the possibility to slowly increase the level of augmentation. The growing availability of dermal fillers for the treatment of breast implants will lead to increased use of various dermal filler types such as polylactic acid, hyaluronic acid, and platelet-rich plasma (PRP) injections, resulting in market expansion. The growing popularity of non-surgical cosmetic treatments is one of the primary drivers of development in the breast fillers industry. According to the Plastic Surgery Statistics report issued in 2020, surgical cosmetic procedures accounted for 2.3 Mn of the 15.6 Mn cosmetic operations performed. Breast augmentation operations have consistently ranked among the top five cosmetic surgery procedures since 2006. The rising importance of physical appearance is a major factor for market expansion. Physical attractiveness is highly valued in society, and many people see cosmetic procedures as a method to improve their look and increase their self-confidence.

Increasing Popularity of Hyaluronic Acid in Breast Augmentation Drives the Market

The hyaluronic acid segment dominated the global market. Hyaluronic acid is a natural chemical that exists inside the body, making it a safe alternative for use as dermal fillers. Dermal filler injections for breast augmentation are minimally invasive, with little to no downtime. This is preferred by patients who wish to avoid the risks and recovery time involved with surgical breast augmentation. Overall, due to its non-permanent nature, flexibility, minimal downtime, and cost-effectiveness, Dermal Filler (Hyaluronic acid) is a frequently used product for breast fillers.

Higher Cost of Breast Augmentation Treatment Is Hindering Market Expansion

One of the primary factors limiting the global expansion of the breast fillers market is the availability of a substantial quantity of published data confirming the potential of acquiring cancer from breast fillers. One of the reasons restricting the market for breast reconstruction surgery and treatments is the relationship between breast fillers and a rare form of cancer known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The average cost of reconstructing a breast in the United States varies from US$ 5,000 to US$ 20,000 or more, depending on the type of treatment, region, and surgeon experience. Plastic surgeons that are experienced and specialised often demand higher fees for their treatments, which can dramatically increase the entire cost of the treatment. This type of surgery frequently necessitates a lengthy hospital stay and specialised medical equipment, which can add to the surgery's cost. Breast fillers need anaesthetic and pain medication, which might raise the overall cost of the treatment. Many women lack enough health coverage or financial resources to bear the expense of the surgery, limiting their access to treatment. These factors are projected to limit the breast fillers market's revenue growth throughout the forecast period.

CollPlant, a regenerative and aesthetics medicine company creating innovative technologies and products for tissue regeneration and organ manufacturing, announced on January, 2023, that it had completed a large animal research for its recombinant human collagen (rhCollagen)-based 3D bioprinted regenerative breast implants, addressing the US$ 2.5 Bn global breast implant market. Based on these encouraging results, the company intends to conduct a follow-up large animal research using commercial-size implants in 2023 to support following human investigations and eventual product commercialization.

AbbVie Inc. (Allergan PLC), BioScience GmbH, Bioxis pharmaceuticals, Croma Pharma GmbH., Cytophil Inc., Galderma SA, Hologic, Inc, Macromed, Huons Global Co. Ltd. (Humedix), Mentor Worldwide LLC (Johnson & Johnson Services, Inc.), Merz Pharma GmbH & Co. KGaA., Prollenium Medical Technologies and Top Dermalare some of the prominent market players operating in the global breast fillers market.

Increasing Breast Augmentation in North America Drives Market Expansion

North America accounts for a sizable portion of the breast fillers market. This is mostly due to the rising demand for breast augmentation surgery driven by a variety of regional entertainment industries as well as women's self-awareness. Women in the United States have a high demand for cosmetic surgeries and treatments, which is one of the major drivers driving market growth. For example, breast augmentation was one of the top five cosmetic surgery procedures performed in the United States in 2022, according to the American Society of Plastic Surgeons. Furthermore, the rising frequency of breast cancer in North America will contribute to the market's expansion. According to the non-profit organisation Breastcancer, breast cancer accounts for around 30% of all new cancer diagnoses in women in the United States each year. As per the Fondation cancer du sein du Québec, about 28,600 women in Canada will be diagnosed with breast cancer annually. As a result, over the forecast period, North America is likely to have a considerable market share in the breast fillers market.

The report provides a detailed overview of the breast fillers market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for breast fillers market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the breast fillers market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the breast fillers market. Some key country and region included in the breast fillers market report as follows:

North America (U.S., Canada)

Latin America (Mexico, Argentina, Brazil, Peru, Chile)

Europe (Germany, France, Italy, U.K., BENELUX, Nordics, Spain, Poland, Russia, CIS)

Asia Pacific (China, ASEAN, India, Japan, South Korea)

Oceania (Australia, New Zealand)

Middle East and Africa (South Africa, GCC Countries, Turkey, Israel, Iran)

The Breast Fillers Market Research Report Covers In-depth Analysis on:

·         Breast fillers market segments

·         Breast fillers market dynamics

·         Breast fillers market value and share analysis

·         Recent trends, restraints, opportunities in breast fillers market

·         Companies & competition involved breast fillers market

·         Latest technologies in breast fillers market

·         Supply chain and value chain breast fillers market

·         Breast fillers market sales and distribution strategies

Breast Fillers Market Growth Highlights:

·         A comprehensive overview of parent market

·         Market dynamics, demand and trends in the industry

·         Current, historical and anticipated market size in terms of volume

·         In-depth market segmentation

·         Competition landscape

·         Key strategies of leading companies and product portfolio

·         Breast fillers industry trends and developments

·         Potential and country, regions and segments exhibiting future growth

·         A detailed viewpoint on breast fillers market forecast by countries

·         Essential information to enhance market position